Arena Pharmaceuticals Announces R&D Leadership Transition
Paul D. Streck, M.D., Appointed as Senior Vice President, Clinical Development and Chief Medical Officer, Bringing Successful Developmentand Launch Experience Across Multiple Therapeutic Indications
“Having Dr. Streck’s deep executive experience as a physician in successful clinical development and medical affairs leadership roles puts Arena in a stronger position as we move toward completing late-stage clinical development into regulatory submission and pre-commercial planning. His proven global leadership roles across therapeutic indications provides for seamless integration for the Company’s current and future clinical and regulatory activities,” said
“On behalf of Arena’s Board of Directors and management team, we would like to thank Chris for his ability to step into a critical role during an important time at our company. We wish him the best in his future endeavors.”
In a rapidly changing global market, we work with a sense of urgency every day to understand the needs of all our stakeholders, identify bold, sometimes disruptive, ideas to get our medicines to patients, and relentlessly execute until it's done.
ARENA - Care More. Act Differently.
Certain statements in this press release are forward-looking statements that involve a number of risks and uncertainties. Such forward-looking statements include, without limitation, statements about Dr. Streck’s expected contributions, Arena's position, drive, portfolio, prioritization, financial position, team, and building of the company. For such statements, Arena claims the protection of the Private Securities Litigation Reform Act of 1995. Actual events or results may differ materially from Arena's expectations. Factors that could cause actual results to differ materially from the forward-looking statements include those disclosed in Arena's filings with the
Vice President, Investor Relations & Corporate Communications
Director, Investor Relations
Arena Media Contact: